New biologically active rubiginones from Streptomyces sp.

Journal of Antibiotics

Volumn 53, Issue 4, 2000, Pages 329-336

  Puder, Carsten ^a   Zeeck, Axel ^a   Beil, Winfried ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 ACETYL RUBIGINONE D2); ANGUCYCLINE DERIVATIVE; CISPLATIN; POLYKETIDE; RUBIGINONE D2; RUBIGINONE DERIVATIVE; RUBIGINONE H; RUBIGINONE I; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOSTASIS; DRUG STRUCTURE; FERMENTATION; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; STREPTOMYCES; TUMOR CELL LINE;

STREPTOMYCES;

EID: 0034069525     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.53.329     Document Type: Article

References (26)

1. GROND, S.; H.-J. LANGER, P. HENNE, I. SATTLER, R. THIERICKE, S. GRABLEY, H. ZäHNER & A. ZEECK: Secondary metabolites by chemical screening. 39. Acyl α-L-rhamnopyranosides, a novel family of secondary metabolites from Streptomyces sp.: Isolation and biosynthesis. Eur. J. Org. Chem. 2000: 929-937, 2000
2. KROHN, K. & J. ROHR: Angucyclines: Total syntheses, new structures, and biosynthetic studies of an emerging new class of antibiotics. In Topics in current chemistry, Vol. 188. Biorganic chemistry. Ed., J. ROHR, pp. 127-195, Springer-Verlag, Berlin-Heidelberg, 1997
3. ROHR, J. & R. THIERICKE: Angucycline group antibiotics. Nat. Prod. Rep. 9: 103-137, 1992
4. GRABLEY, S.; R. THIERICKE & A. ZEECK: The chemical screening approach. In Drug discovery from nature. Eds., S. GRABLEY & R. THIERICKE, pp. 124-148, Springer, Berlin-Heidelberg, 1999
5. OKA, M.; H. KAMEI, Y. HAMAGISHI, K. TOMITA, T. MIYAKI, M. KONISHI & T. OKI: Chemical and biological properties of rubiginone, a complex of new antibiotics with vincristine-cytotoxicity potentiating activity. J. Antibiotics 43: 967-976, 1990
6. MAEHR, H.; C.-M. LIU, M. LIU, A. PERROTTA, J. M. SMALLHEER, T. H. WILLIAMS & J. F. BLOUNT: Microbial products. 6. Five novel metabolites related to benz[a]anthracene from an unidentified actinomycete designated X-14881. J. Antibiotics 35: 1627-1631, 1982
7. RICKARDS, R. W. & J.-P. Wu: Fujianmycins A and B, new benz[a]anthraquinone antibiotics from a Streptomyces species. J. Antibiotics 38: 513-515, 1985
8. PUDER, C.: Neue Streptazoline und Rubiginone aus Streptomyceten durch Variation der Kultivierungsbedingungen sowie Untersuchungen zur Struktur und Biosynthese der Rubromycine. Ph. D. Thesis, Univ. Göttingen, 1998
9. OKA, M.; M. KONISHI, T. OKI & M. OHASHI: Absolute configuration of the rubiginones and photo-induced oxidation of the Cl hydroxy of the antibiotics to a ketone. Tetrahedron Lett. 31: 7473-7474, 1990
10. KIMURA, K.-I.; F. KANOU, H. KOSHINO, M. URAMOTO & M. YOSHIHAMA: SNA-8073-B, a new isotetracenone antibiotic inhibits prolyl endopeptidase. I. Fermentation, isolation and biological properties. J. Antibiotics 50: 291-296, 1997
11. HELMCHEN, G.: Über eine neue Methode zur Bestimmung der absoluten Konfiguration von chiralen sekundären Alkoholen und Aminen: NMR-Spektroskopie von diastereomeren Estern und Aminen der α-Phenylbutter-und Hydratropasäure. Tetrahedron Lett. 1974: 1527-1530, 1974
12. SASAKI, T.; S. GOMI, M. SEZAKI, Y. TAKEUCHI, Y. KODAMA & K. KAWAMURA: New antibiotics SF2315A and B produced by an Excellospora sp. II. The structure elucidation. J. Antibiotics 41: 843-848, 1988
13. TSUKUDA, E.; T. TANAKA, K. OCHIAI, H. KONDO, M. YOSHIDA, T. AGATSUMA, Y. SAITOH, S. TESHIBA & Y. MATSUDA: EI-1507-1 and -2, novel interleukin-1β converting enzyme inhibitors produced by Streptomyces sp. E-1507. J. Antibiotics 49: 333-339, 1996
14. BETHE, B.: Ausarbeitung von Methoden und Konzepten zum Auffinden und Bewerten von Biosyntheseleistungen im Sekundärstoffwechsel sowie Isolierung und Strukturaufklärung der Sekundärstoffe des Streptomyceten Stammes Gö 40/14. Ph. D. Thesis, Univ. Göttingen, 1994
15. GREVER, M. R.; S. A. SCHEPARTZ & B. A. CHABNER: The National Cancer Institute: Cancer drug discovery and development program. Semin. Oncol. 19: 622-638, 1992
16. SKEHAN, P.; R. STORENG, D. SCUDIERO, A. MONKS, J. McMAHON, D. VISTICA, J. T. WARREN, H. BOKESCH, S. KENNEDY & M. R. BOYD: New colorimetric cytotoxicity assay for anticancer drug screening. J. Nat. Cancer Inst. 82: 1107-1112, 1990
17. ETOH, H.; M. IGUCHI, T. NAGASAWA, Y. TANI, H. YAMADA & H. FUKAMI: Structures of rhodonocardins produced by a Nocardia sp. Agric. Biol. Chem. 51: 1819-1824, 1987
18. NAGASAWA, T.; H. FUKAO, H. IRIE & H. YAMADA: Sakyomycins A, B, C and D: New quinone-type antibiotics produced by a strain of Nocardia. J. Antibiotics 37: 693-699, 1984
19. KERN, D. L.; J. P. SCHAUMBERG, G. C. HOKANSON & J. C. FRENCH: PD 116,779, a new antitumor antibiotic of the benz[a]anthraquinone class. J. Antibiotics 39: 469-470, 1986
20. VOLKMANN, C.; E. ROSSNER, M. METZLER, H. ZÄHNER & A. ZEECK: Momofulvenone A and B, new benzo[b]fluorene quinones from Streptomyces. Liebigs Ann. 1995: 1169-1172, 1995
21. GOULD, S. J.: Biosynthesis of the kinamycins. Chem. Rev. 97: 2499-2509, 1997
22. GERLITZ, M.; G. UDVARNOKI & J. ROHR: Biosynthesis of novel emycins from the mutant strain Streptomyces cellulosae ssp. griseoincarnatus 1114-2. Angew. Chem. Int. Ed. Engl. 34: 1617-1620, 1995
23. SENDA, S. & H. SETO (Hoechst Japan Ltd.): Fermentative production of new benzanthracene compound as antitumor agent. Eur. Pat. Appl. EP 435,221, Jul. 3, 1991
24. GRABLEY, S.; P. HAMMANN, K. HüTTER, H. KLUGE, R. THIERICKE, J. WINK & A. ZEECK: Secondary metabolites by chemical screening. Part 19. SM 196 A and B, novel biologically active angucyclinones from Streptomyces sp. J. Antibiotics 44: 670-673, 1991
25. 2, (±)-emycin A, and related analogues. J. Chem. Soc. Perkin Trans I 1995: 1019-1028, 1995
26. 2 and (+)-ochromycinone. Chem. Commun. 1999: 817-818, 1999